Literature DB >> 8930407

Expression of G1 cyclins, cyclin-dependent kinases, and cyclin-dependent kinase inhibitors in androgen-induced prostate proliferation in castrated rats.

Y Chen1, A I Robles, L A Martinez, F Liu, I B Gimenez-Conti, C J Conti.   

Abstract

Androgen induces prostate cell proliferation in the castrated rat. We hypothesized that G1 cyclins, cyclin-dependent kinases (cdk), and cdk inhibitors mediate this cellular response to mitogenic signals. In this study, induction of cyclins D1, D2, D3, E, and cdks 2, 4, and 6 expression was observed at various time points during testosterone replacement in the ventral prostate of castrated rats. The induction followed prostate epithelium proliferation, which peaked at 48 h and decreased at 120 h during the treatment. The study of cyclin/cdk complex formation revealed that more cyclin D1/cdk4 and cyclin D1/cdk6 complexes were formed at 48 h than at 120 h of treatment, but cyclin D1/cdk2 complexes remained the same. Furthermore, both hyperphosphorylated and hypophosphorylated forms of Rb were detected at 48 h, but only the hypophosphorylated form was detected at 120 h of treatment. p21Cip1, which was very abundant in the ventral prostate of castrated and intact rats, was not detected when the prostate started proliferation and increased gradually as proliferation decreased during the androgen treatment. Meanwhile, p27Kip1 dramatically increased after androgen treatment, and the induction levels were less at the peak of prostate proliferation and higher when proliferation was low. The results presented here suggest that expression of G1 cyclins and their related kinases and kinase inhibitors are well regulated after androgen replacement in the ventral prostate of castrated rats. The cooperation between these cell cycle regulators leads to a well-controlled prostate regeneration.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8930407

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  25 in total

1.  Androgen receptor remains critical for cell-cycle progression in androgen-independent CWR22 prostate cancer cells.

Authors:  Xin Yuan; Tong Li; Hongyun Wang; Tao Zhang; Moumita Barua; Robert A Borgesi; Glenn J Bubley; Michael L Lu; Steven P Balk
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

Review 2.  The convergence of hormone regulation and cell cycle in prostate physiology and prostate tumorigenesis.

Authors:  Joanne N Davis; Mark L Day
Journal:  Mol Biotechnol       Date:  2002-10       Impact factor: 2.695

3.  Length of the human androgen receptor glutamine tract determines androgen sensitivity in vivo.

Authors:  Ulla Simanainen; Michele Brogley; Yan Ru Gao; Mark Jimenez; D Tim Harwood; David J Handelsman; Diane M Robins
Journal:  Mol Cell Endocrinol       Date:  2011-06-01       Impact factor: 4.102

4.  A high-throughput bimolecular fluorescence complementation protein-protein interaction screen identifies functional Arabidopsis CDKA/B-CYCD4/5 complexes.

Authors:  Joanna Boruc; Dirk Inzé; Eugenia Russinova
Journal:  Plant Signal Behav       Date:  2010-10-01

5.  17alpha-estradiol inhibits LAPC-4 prostatic tumor cell proliferation in cell cultures and tumor growth in xenograft animals.

Authors:  Yaming Qiao; Zhi-Kai Zhang; Li-Qun Cai; Chen Tan; Julianne L Imperato-McGinley; Yuan-Shan Zhu
Journal:  Prostate       Date:  2007-12-01       Impact factor: 4.104

6.  Neuroendocrine differentiation in prostate cancer.

Authors:  Yin Sun; Junyang Niu; Jiaoti Huang
Journal:  Am J Transl Res       Date:  2009-02-05       Impact factor: 4.060

7.  Retinoic acid receptor alpha is required for synchronization of spermatogenic cycles and its absence results in progressive breakdown of the spermatogenic process.

Authors:  Sanny S W Chung; Wengkong Sung; Xiangyuan Wang; Debra J Wolgemuth
Journal:  Dev Dyn       Date:  2004-08       Impact factor: 3.780

8.  Tumor suppressive miR-124 targets androgen receptor and inhibits proliferation of prostate cancer cells.

Authors:  X-B Shi; L Xue; A-H Ma; C G Tepper; R Gandour-Edwards; H-J Kung; R W deVere White
Journal:  Oncogene       Date:  2012-10-15       Impact factor: 9.867

9.  Bypass mechanisms of the androgen receptor pathway in therapy-resistant prostate cancer cell models.

Authors:  Rute B Marques; Natasja F Dits; Sigrun Erkens-Schulze; Wytske M van Weerden; Guido Jenster
Journal:  PLoS One       Date:  2010-10-19       Impact factor: 3.240

10.  Cell proliferation and expression of cell cycle regulatory proteins that control the G1/S transition are age dependent and lobe specific in the Brown Norway rat model of prostatic hyperplasia.

Authors:  Jinchun Yan; Terry R Brown
Journal:  Endocrinology       Date:  2007-10-25       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.